Both in Pharmaceuticals
Jaguar Health vs Artelo Biosciences
Over the past year JAGX returned −99.3% and ARTL returned −97.6%; their daily moves had a correlation of -0.08.
JAGX −99.3% ARTL −97.6%Growth of $1, one year, split-adjusted
| Metric | JAGX | ARTL |
|---|---|---|
| Price | $3.53 | $2.70 |
| Market cap | $6.9M | $1.5M |
| Today | +207.19% | −1.46% |
| 1 month | +156.4% | −32.0% |
| 6 months | −96.6% | −93.2% |
| Year to date | −98.4% | −91.8% |
| 1 year | −99.3% | −97.6% |
| Revenue growth (YoY) | −58.9% | — |
| Gross margin | 15.8% | — |
| Net margin | −1036.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.2× | — |
| Net cash | -$11.8M | $4.2M |
| Dividend yield | — | — |
| Volatility (60d) | 1,064.0% | 651.1% |
| Short % of float | 1.2% | 1.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).